Viewing nowCombinationCanderol 10/16 mg (Rosuvastatin, Candesartan)
Rosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 202008720 · Approved 2020.12.11 · Insurance code 657808210
Improvement of dyslipidemia; treatment of hypertension and heart failure; suppression of atherosclerosis progression and cardiovascular risk
This medication is used for patients who need to administer two ingredients, Candesartan Cilexetil and Rosuvastatin, together. First, Candesartan Cilexetil primarily helps patients with essential hypertension and heart failure with impaired left ventricular function. It is particularly suitable for cases requiring additional therapy for ACE inhibitors or for patients with poor tolerance. Rosuvastatin is primarily used for diseases associated with hypercholesterolemia and is administered as an adjunctive therapy when dietary therapy is insufficient. Additionally, it aids patients with homozygous familial hypercholesterolemia, dysbetalipoproteinemia. Moreover, it contributes to reducing the risk of stroke, myocardial infarction, and arterial revascularization in middle-aged people with elevated high-sensitivity C-reactive protein levels and cardiovascular disease risk factors. Therefore, this medication improves hypertension, heart failure, hyperlipidemia, and the risk of cardiovascular disease.
This medicine is intended for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg, exercising particular caution in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of 2 weeks or longer, up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, renal impairment, or mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
Essential hypertension — Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. Heart failure — Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergic reactions to this medication, severely impaired liver function, and women who are pregnant or breastfeeding. Additionally, it is contraindicated in patients with specific diseases such as severe kidney disorders, myopathy, or hereditary angioedema. Elderly patients, those with hyperkalemia, or patients with compromised liver function should exercise special caution when using this medication and should regularly undergo liver and kidney function tests. This medication can cause muscle-related side effects, so if symptoms like myalgia or weakness occur, the patient should consult a doctor immediately, and blood tests may be required to check for muscle damage. Also, medication interactions may occur if taken with other antihypertensives, diuretics, certain antibiotics, antifungals, etc., so the patient must inform healthcare professionals of all medications currently being taken. Dizziness may occur when driving or operating machinery, so caution is advised, and it should be stored out of reach of children.
Headache, nasopharyngitis, localized infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, hyperglycemia, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, dizziness, positional dizziness, Molluscum contagiosum, periodontitis, inflammation, foreign body sensation, musculoskeletal pain, neck pain, cataract, nausea, hyperglycemia, decreased serum sodium, rash, urticaria, angioedema, asthenia, fever, sensory disturbance, low back pain, myalgia, anxiety, depression, somnolence, dyspnea, hematuria, increased sweating, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia and systemic symptoms-associated drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, paralysis, tension increase, syncope, facial flushing, weight gain, facial edema, thirst, sleep disturbance, decreased libido, forgetfulness, anorexia, increased appetite, tinnitus, taste disturbance, erectile dysfunction, constipation, abdominal pain, pancreatitis, myopathy, rhabdomyolysis, interstitial pneumonia, shock, syncope, loss of consciousness, increased blood pressure, orthostatic hypotension, cerebral infarction, spondyloarthritis myelopathy, musculoskeletal discomfort, pneumonia, femur fracture, contusion, unstable angina, idiopathic pulmonary fibrosis, productive cough, exacerbation of hypertension, unstable blood pressure, vertigo, positional vertigo, adrenal insufficiency, acute renal failure, acute renal failure, increased serum creatinine, dizziness due to blood pressure reduction, lethargy, myalgia, muscle weakness, muscle cramps, myalgia, myopathy, rhabdomyolysis, transaminase elevation, increased ALT, increased AST, increased γ-GTP, liver dysfunction, jaundice, thrombocytopenia, thrombocytopenia, increased serum creatinine, blood pressure reduction, hypotension, shock, syncope, loss of consciousness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best stored at room temperature, between 1 to 30 degrees Celsius.
Yellow round film-coated tablets
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.